These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1142 related items for PubMed ID: 17509946

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Effect of hepatitis B and C virus infections on the natural history of compensated cirrhosis: a cohort study of 297 patients.
    Fattovich G, Pantalena M, Zagni I, Realdi G, Schalm SW, Christensen E, European Concerted Action on Viral Hepatitis (EUROHEP).
    Am J Gastroenterol; 2002 Nov; 97(11):2886-95. PubMed ID: 12425564
    [Abstract] [Full Text] [Related]

  • 5. Hepatitis B virus infection and hepatocellular carcinoma among parous Taiwanese women: nationwide cohort study.
    Fwu CW, Chien YC, Kirk GD, Nelson KE, You SL, Kuo HS, Feinleib M, Chen CJ.
    J Natl Cancer Inst; 2009 Jul 15; 101(14):1019-27. PubMed ID: 19535774
    [Abstract] [Full Text] [Related]

  • 6. Carriers of inactive hepatitis B virus are still at risk for hepatocellular carcinoma and liver-related death.
    Chen JD, Yang HI, Iloeje UH, You SL, Lu SN, Wang LY, Su J, Sun CA, Liaw YF, Chen CJ, Risk Evaluation of Viral Load Elevation and Associated Liver Disease/Cancer in HBV (REVEAL-HBV) Study Group.
    Gastroenterology; 2010 May 15; 138(5):1747-54. PubMed ID: 20114048
    [Abstract] [Full Text] [Related]

  • 7. Clinical and pathological factors associated with the development of hepatocellular carcinoma in patients with hepatitis virus-related cirrhosis: a long-term follow-up study.
    Rodríguez-Díaz JL, Rosas-Camargo V, Vega-Vega O, Morales-Espinosa D, Mendez-Reguera A, Martínez-Tlahuel JL, Gamboa-Domínguez A, Arrieta O.
    Clin Oncol (R Coll Radiol); 2007 Apr 15; 19(3):197-203. PubMed ID: 17359907
    [Abstract] [Full Text] [Related]

  • 8. The role of diabetes in hepatocellular carcinoma: a case-control study among United States Veterans.
    El-Serag HB, Richardson PA, Everhart JE.
    Am J Gastroenterol; 2001 Aug 15; 96(8):2462-7. PubMed ID: 11513191
    [Abstract] [Full Text] [Related]

  • 9. The impact of type 2 diabetes on the development of hepatocellular carcinoma in different viral hepatitis statuses.
    Wang CS, Yao WJ, Chang TT, Wang ST, Chou P.
    Cancer Epidemiol Biomarkers Prev; 2009 Jul 15; 18(7):2054-60. PubMed ID: 19549812
    [Abstract] [Full Text] [Related]

  • 10. Occult hepatitis B virus infection is associated with the development of hepatocellular carcinoma in chronic hepatitis C patients.
    Squadrito G, Pollicino T, Cacciola I, Caccamo G, Villari D, La Masa T, Restuccia T, Cucinotta E, Scisca C, Magazzu D, Raimondo G.
    Cancer; 2006 Mar 15; 106(6):1326-30. PubMed ID: 16453330
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Natural history of compensated cirrhosis in the Child-Pugh class A compared between 490 patients with hepatitis C and 167 with B virus infections.
    Kobayashi M, Ikeda K, Hosaka T, Sezaki H, Someya T, Akuta N, Suzuki F, Suzuki Y, Saitoh S, Arase Y, Miyakawa Y, Kumada H.
    J Med Virol; 2006 Apr 15; 78(4):459-65. PubMed ID: 16482557
    [Abstract] [Full Text] [Related]

  • 13. Virological suppression does not prevent the development of hepatocellular carcinoma in HBeAg-negative chronic hepatitis B patients with cirrhosis receiving oral antiviral(s) starting with lamivudine monotherapy: results of the nationwide HEPNET. Greece cohort study.
    Papatheodoridis GV, Manolakopoulos S, Touloumi G, Vourli G, Raptopoulou-Gigi M, Vafiadis-Zoumbouli I, Vasiliadis T, Mimidis K, Gogos C, Ketikoglou I, Manesis EK, HEPNET. Greece Cohort Study Group.
    Gut; 2011 Aug 15; 60(8):1109-16. PubMed ID: 21270118
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Risk and predictors of mortality associated with chronic hepatitis B infection.
    Iloeje UH, Yang HI, Jen CL, Su J, Wang LY, You SL, Chen CJ, Risk Evaluation of Viral Load Elevation and Associated Liver Disease/Cancer-Hepatitis B Virus Study Group.
    Clin Gastroenterol Hepatol; 2007 Aug 15; 5(8):921-31. PubMed ID: 17678844
    [Abstract] [Full Text] [Related]

  • 16. The role of previous hepatitis B virus infection and heavy smoking in hepatitis C virus-related hepatocellular carcinoma.
    Chiba T, Matsuzaki Y, Abei M, Shoda J, Tanaka N, Osuga T, Aikawa T.
    Am J Gastroenterol; 1996 Jun 15; 91(6):1195-203. PubMed ID: 8651170
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Decreased incidence of hepatocellular carcinoma in hepatitis B vaccinees: a 20-year follow-up study.
    Chang MH, You SL, Chen CJ, Liu CJ, Lee CM, Lin SM, Chu HC, Wu TC, Yang SS, Kuo HS, Chen DS, Taiwan Hepatoma Study Group.
    J Natl Cancer Inst; 2009 Oct 07; 101(19):1348-55. PubMed ID: 19759364
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 58.